R ICHTLIJN DIAGNOSTIEK MENTALE RETARDATIEAlopecia en “brittle hair”ziekte van Refsumchondrodysplasia punctata, ARchondrodysplasia punctata ADrizomele chondrodysplasia punctatatrichothiodystrophie266500302950302960215100601675Cutis laxa fragiele X syndroom 309550Nagelafwijkingen -/dystrofie incontinentia pigmentisyndromen met ecto<strong>de</strong>rmale dyspla-308300siemultipele carboxylase <strong>de</strong>ficiëntieziekte van Menkestrichothiodystrofie253270309400601675OMIM = Online Men<strong>de</strong>lian Inheritance in Men : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM48
LiteratuurAase JM. Diagnostic Dysmorphology. New York: Plenum Press, 1990.Al-Qudah AA. Screening for congenital hypothyroidism in cognitively <strong>de</strong>layed children. Ann Trop Paediatr1998;18:285-288.Arvio M, Peippo M, Simola KO. Applicability of a checklist for clinical screening of the fragile X syndrome.Clin.Genet 1997;52:211-215.Bachman JA, Bachman WG, Franzel AS, Marcuss MC. Preteaching <strong>de</strong>velopmentally <strong>de</strong>layed preschoolersto aid vision screening. Optom Vis Sci 1994;71:713-716.Battaglia A, Carey JC. Diagnostic evaluation of <strong>de</strong>velopmental <strong>de</strong>lay/mental retardation: An overview. AmJ Med Genet 2003;117C:3-14.Bogaert P van, Baleriaux D, Christophe C, Szliwowski HB. MRI of patients with cerebral palsy and normalCT-scan. Neuroradiol 1992;34:52-56.Borstlap R (red.). Leidraad <strong>voor</strong> <strong>de</strong> medische begeleiding van kin<strong>de</strong>ren met het Down Syndroom. Samengestelddoor <strong>de</strong> Werkgroep Down Syndroom van <strong>de</strong> Sectie Erfelijke en Aangeboren Aandoeningen van <strong>de</strong>Ne<strong>de</strong>rlandse Vereniging <strong>voor</strong> Kin<strong>de</strong>rgeneeskun<strong>de</strong> (1998).Bouhadiaba Z, Dacher J, Monroc M, Vanhulle C, Menard JF, Kalifa G. Apport <strong>de</strong> l’IRM cerebrale al’exploration <strong>de</strong>s retards psychomoteurs <strong>de</strong> l’enfant. J Radiol 2000;81:870-873.Butler MG, Singh DN. Clinical and cytogenetic survey of institutionalized mentally retar<strong>de</strong>d patients withemphasis on the fragile-X syndrome. J Intellect Disabil Res 1993;37:131-142.Cone-Wesson B, Vohr BR, Sininger YS, Wi<strong>de</strong>n JE, Folsom RC, Gorga MP, Norton SJ. I<strong>de</strong>ntification ofneonatal hearing impairment: infants with hearing loss. Ear Hear 2000;21:488-507.Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham JM Jr, Jones MC,Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz J. Evaluation of mental retardation:recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet1997;72:468-477.Ens-Dokkum MH. Risico’s, risicofactoren en kansen in <strong>de</strong> ontwikkeling van kin<strong>de</strong>ren met een gehoorstoornis.Tijdschr Kin<strong>de</strong>rgeneeskd 2003;71:180-186.Fernan<strong>de</strong>s J, Saudubray JM, Van <strong>de</strong>n Berghe. Inborn Metabolic Diseases: Diagnosis and Treatment.Springer Verlag, 2000.Fort P, Lifshitz F, Bellisario R, Davis J, Lanes R, Pugliese M, Richman R, Post EM, David R. Abnormalitiesof thyroid function in infants with Down Syndrome. J Pediatr 1984;104:545-549.Gerrits GPJM, LAH Monnens, FJM Gabreëls, RA <strong>de</strong> Abreu, A Koster en JMF Trijbels. Cerebrospinalfluid amino acids, purines and pyrimidines as a tool in <strong>de</strong> study of metabolic brain diseases. J Inher MetabDis 1993;16:670-675.Giangreco CA, Steele MW, Aston CE, Cummins JH, Wenger SL. A simplified six-item checklist forscreening for fragile X syndrome in the pediatric population. J Pediatr 1996;129:611-614.49